Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23709439)

1.

Does venous thromboembolism affect rehabilitation after hip fracture surgery?

Lee YK, Choi YH, Ha YC, Lim JY, Koo KH.

Yonsei Med J. 2013 Jul;54(4):1015-9. doi: 10.3349/ymj.2013.54.4.1015.

2.

Little impact of antiplatelet agents on venous thromboembolism after hip fracture surgery.

Ji HM, Lee YK, Ha YC, Kim KC, Koo KH.

J Korean Med Sci. 2011 Dec;26(12):1625-9. doi: 10.3346/jkms.2011.26.12.1625. Epub 2011 Nov 29.

3.

Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery.

Sasaki S, Miyakoshi N, Matsuura H, Saitoh H, Kudoh D, Shimada Y.

J Orthop Sci. 2009 Sep;14(5):491-6. doi: 10.1007/s00776-009-1365-4. Epub 2009 Oct 3.

PMID:
19802659
4.

Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.

Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W, Cohen E, Zukor D.

Chest. 2005 Nov;128(5):3364-71.

PMID:
16304285
5.

Symptomatic venous thromboembolism following a hip fracture.

McNamara I, Sharma A, Prevost T, Parker M.

Acta Orthop. 2009 Dec;80(6):687-92. doi: 10.3109/17453670903448273.

6.

Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.

Dahl OE, Gudmundsen TE, Pripp AH, Aanesen JJ.

Clin Appl Thromb Hemost. 2014 Mar;20(2):117-23. doi: 10.1177/1076029613499820. Epub 2013 Oct 10.

PMID:
24113492
7.

Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels.

Grossfeld A, Dekel S, Lerman Y, Sherman S, Atzmony L, Salai M, Justo D.

Clin Biochem. 2013 Jan;46(1-2):54-8. doi: 10.1016/j.clinbiochem.2012.09.011. Epub 2012 Sep 18.

PMID:
23000313
8.

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators.

Arch Intern Med. 2003 Jun 9;163(11):1337-42.

PMID:
12796070
9.

Economic consequences of venous thromboembolism following major orthopedic surgery.

Oster G, Ollendorf DA, Vera-Llonch M, Hagiwara M, Berger A, Edelsberg J.

Ann Pharmacother. 2004 Mar;38(3):377-82. Epub 2004 Jan 12.

PMID:
14742829
10.

Symptomatic venous thromboembolism and mortality in orthopaedic surgery - an observational study of 45 968 consecutive procedures.

Lapidus LJ, Ponzer S, Pettersson H, de Bri E.

BMC Musculoskelet Disord. 2013 Jun 4;14:177. doi: 10.1186/1471-2474-14-177.

11.

Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.

Mismetti P, Samama CM, Rosencher N, Vielpeau C, Nguyen P, Deygas B, Presles E, Laporte S; PROPICE Study Group.

Thromb Haemost. 2012 Jun;107(6):1151-60. doi: 10.1160/TH11-09-0640. Epub 2012 Apr 4.

PMID:
22476471
12.

Symptomatic venous thrombo-embolism in low-energy isolated fractures in hospitalised patients.

Prensky C, Urruela A, Guss MS, Karia R, Lenzo TJ, Egol KA.

Injury. 2013 Aug;44(8):1135-9. doi: 10.1016/j.injury.2013.04.018. Epub 2013 May 14.

PMID:
23684349
13.

Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study.

Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Samama CM; ESCORTE group.

J Thromb Haemost. 2005 Sep;3(9):2006-14.

PMID:
16102107
14.

Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.

Ollendorf DA, Vera-Llonch M, Oster G.

Am J Health Syst Pharm. 2002 Sep 15;59(18):1750-4.

PMID:
12298113
15.

[Risk early warning and multimodal prevention of postoperative venous thromboembolism for hip fractures].

Ruan ZY, He YQ, Zeng QH, Zhang G, Xiang C, Zhu QW.

Zhongguo Gu Shang. 2012 Oct;25(10):800-3. Chinese.

PMID:
23342790
16.

Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study.

Markovic-Denic L, Zivkovic K, Lesic A, Bumbasirevic V, Dubljanin-Raspopovic E, Bumbasirevic M.

Int Orthop. 2012 Jun;36(6):1299-305. doi: 10.1007/s00264-011-1466-5. Epub 2012 Jan 4.

17.

Incidence of venous thromboembolism in pelvic and acetabular fractures in the Japanese population.

Niikura T, Lee SY, Oe K, Koh A, Koga T, Dogaki Y, Okumachi E, Kurosaka M.

J Orthop Sci. 2012 May;17(3):233-8. doi: 10.1007/s00776-012-0203-2. Epub 2012 Mar 20.

PMID:
22453360
18.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

19.
20.

Frequency and timing of clinical venous thromboembolism after major joint surgery.

Bjørnarå BT, Gudmundsen TE, Dahl OE.

J Bone Joint Surg Br. 2006 Mar;88(3):386-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk